Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.
Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.
复制标题
DOI:
10.3389/fcimb.2020.575613
复制
发表时间:
2020
影响因子:
5.7
通讯作者:
Yassine HM
中科院分区:
文献类型:
--
作者:
Al Khatib HA;Benslimane FM;Elbashir IE;Coyle PV;Al Maslamani MA;Al-Khal A;Al Thani AA;Yassine HM
Background: The ongoing pandemic of SARS-COV-2 has already infected more than eight million people worldwide. The majority of COVID-19 patients either are asymptomatic or have mild symptoms. Yet, about 15% of the cases experience severe complications and require intensive care. Factors determining disease severity are not yet fully characterized. Aim: Here, we investigated the within-host virus diversity in COVID-19 patients with different clinical manifestations. Methods: We compared SARS-COV-2 genetic diversity in 19 mild and 27 severe cases. Viral RNA was extracted from nasopharyngeal samples and sequenced using the Illumina MiSeq platform. This was followed by deep-sequencing analyses of SARS-CoV-2 genomes at both consensus and sub-consensus sequence levels. Results: Consensus sequences of all viruses were very similar, showing more than 99.8% sequence identity regardless of the disease severity. However, the sub-consensus analysis revealed significant differences in within-host diversity between mild and severe cases. Patients with severe symptoms exhibited a significantly (p-value 0.001) higher number of variants in coding and non-coding regions compared to mild cases. Analysis also revealed higher prevalence of some variants among severe cases. Most importantly, severe cases exhibited significantly higher within-host diversity (mean = 13) compared to mild cases (mean = 6). Further, higher within-host diversity was observed in patients above the age of 60 compared to the younger age group. Conclusion: These observations provided evidence that within-host diversity might play a role in the development of severe disease outcomes in COVID-19 patients; however, further investigations are required to elucidate this association.
登录
查看更多内容
DOI:
10.1038/nrmicro.2016.81
发表时间:
2016-08
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
de Wit E;van Doremalen N;Falzarano D;Munster VJ
通讯作者:
Munster VJ
DOI:
10.1016/j.jaci.2010.10.048
发表时间:
2011-02
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Huang YJ;Nelson CE;Brodie EL;Desantis TZ;Baek MS;Liu J;Woyke T;Allgaier M;Bristow J;Wiener-Kronish JP;Sutherland ER;King TS;Icitovic N;Martin RJ;Calhoun WJ;Castro M;Denlinger LC;Dimango E;Kraft M;Peters SP;Wasserman SI;Wechsler ME;Boushey HA;Lynch SV;National Heart, Lung, and Blood Institute's Asthma Clinical Research Network
通讯作者:
National Heart, Lung, and Blood Institute's Asthma Clinical Research Network
影响因子:
5.4
作者:
Cabot, B;Martell, M;Gómez, J
通讯作者:
Gómez, J
影响因子:
6.7
作者:
Lauring AS;Andino R
通讯作者:
Andino R
影响因子:
3.7
作者:
Guan WZ;Qiu GF;Feng-Liu
通讯作者:
Feng-Liu